IA
XENE icon

IFP Advisors’s Xenon Pharmaceuticals XENE Stock Holding History

IFP Advisors’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Hold
1,871
– – ﹤0.01% 1896
2026
Q1 		$109K Sell
1,871
-6
-0.3% -$276 ﹤0.01% 1791
2025
Q4 		$84.1K Sell
1,877
-31
-2% -$1.3K ﹤0.01% 1908
2025
Q3 		$76.6K Buy
1,908
+43
+2% +$1.51K ﹤0.01% 1851
2025
Q2 		$61.5K Sell
1,865
-56
-3% -$1.83K ﹤0.01% 1937
2025
Q1 		$64.6K Sell
1,921
-37
-2% -$1.41K ﹤0.01% 1766
2024
Q4 		$76.9K Sell
1,958
-19
-1% -$786 ﹤0.01% 1602
2024
Q3 		$77.8K Sell
1,977
-125
-6% -$5.04K ﹤0.01% 1518
2024
Q2 		$82K Sell
2,102
-19
-0.9% -$759 ﹤0.01% 1445
2024
Q1 		$91.3K Sell
2,121
-27
-1% -$1.24K ﹤0.01% 1332
2023
Q4 		$98.9K Sell
2,148
-30
-1% -$1.06K ﹤0.01% 1248
2023
Q3 		$74.4K Hold
2,178
– – ﹤0.01% 1397
2023
Q2 		$83.8K Buy
2,178
+1,178
+118% +$46.8K ﹤0.01% 1395
2023
Q1 		$5.7K Hold
1,000
– – ﹤0.01% 2510
2022
Q4 		$6K Hold
1,000
– – ﹤0.01% 3733
2022
Q3 		$6K Hold
1,000
– – ﹤0.01% 3968
2022
Q2 		$6K Hold
1,000
– – ﹤0.01% 3723
2022
Q1 		$6K Hold
1,000
– – ﹤0.01% 3723
2021
Q4 		$31K Hold
1,000
– – ﹤0.01% 1757
2021
Q3 		$15K Hold
1,000
– – ﹤0.01% 2120
2021
Q2 		$19K Hold
1,000
– – ﹤0.01% 1962
2021
Q1 		$18K Hold
1,000
– – ﹤0.01% 1899
2020
Q4 		$15K Hold
1,000
– – ﹤0.01% 1914
2020
Q3 		$11K Hold
1,000
– – ﹤0.01% 1880
2020
Q2 		$12K Hold
1,000
– – ﹤0.01% 1765
2020
Q1 		$11K Buy
+1,000
New +$14.2K ﹤0.01% 1741

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

IFP Advisors's XENE Position: Q2 2026 in Review

IFP Advisors held its Xenon Pharmaceuticals (XENE) position steady in Q2 2026 at 1,871 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #1896.

IFP Advisors first reported a position in XENE in Q1 2020 and has held it in 26 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • IFP Advisors held 1,871 shares of Xenon Pharmaceuticals worth $113K as of Q2 2026.
  • IFP Advisors left its Xenon Pharmaceuticals share count unchanged in Q2 2026.
  • Xenon Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #1896 holding.
  • IFP Advisors first reported a position in Xenon Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.